Interferon beta-1b bioanalogue (Generium)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon beta-1b bioanalogue (Generium)
Drug Alias Nameinterferon beta-1b follow-on biologicInfibeta
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunomodulatorsInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsMultiple Sclerosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryKazakhstan
Original Approved Date2011/01/01
Country/TerritoryKazakhstan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeL03AB08
Related LinksN/A